Amrutanjan Health Care Limited (BOM:590006)
India · Delayed Price · Currency is INR 513.30
-4.30 (-0.83%)
At close: Nov 6, 2026
Amrutanjan Health Care Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 5,273 | 5,028 | 4,520 | 4,214 | 3,798 | 4,059 |
Revenue Growth | 12.17% | 11.24% | 7.26% | 10.96% | -6.45% | 21.90% |
Gross Profit Gross Profit Growth | 2,695 | 2,530 | 2,230 | 2,043 | 1,924 | 2,221 |
Operating Income Operating Income Growth | 616.82 | 630.37 | 532.59 | 472.47 | 418.55 | 798.41 |
Net Income Net Income Growth | 572.91 | 579.18 | 508.35 | 449.73 | 398.35 | 671.89 |
Earnings Per Share EPS Growth | 19.82 | 20.03 | 17.58 | 15.50 | 13.63 | 22.98 |
EPS Growth | 1.15% | 13.94% | 13.44% | 13.70% | -40.69% | 9.79% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Others Others Growth | 27.68 | 13.94 | 8.56 | 20.6 | 17.25 |
Beverages Beverages Growth | 315.61 | 364.3 | 399.81 | 324.63 | 319.05 |
OTC Products (Excl. Women Hygiene) OTC Products (Excl. Women Hygiene) Growth | 3,283 | 2,900 | 2,751 | - | - |
Women's Hygiene & Personal Care Women's Hygiene & Personal Care Growth | 1,399 | 1,240 | 1,053 | - | - |
Total Total Growth | 5,026 | 4,518 | 4,212 | 3,796 | 4,058 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 262.46 | 1,705 | 1,953 | 2,072 | 1,825 | 2,011 |
Total Debt Total Debt Growth | 18.9 | 17.77 | 20.78 | 17.28 | 9.09 | 8.8 |
Net Cash (Debt) Net Cash Growth | 243.56 | 1,687 | 1,932 | 2,054 | 1,816 | 2,002 |
Net Cash Growth | -88.15% | -12.69% | -5.96% | 13.15% | -9.31% | 15.06% |
Net Cash Per Share Net Cash Per Share Growth | 8.43 | 58.35 | 66.83 | 70.79 | 62.12 | 68.47 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 229.01 | 359.68 | 508.99 | 279.11 | 201.81 | 521.96 |
Capital Expenditures CapEx Growth | -727.59 | -550.04 | -355.53 | -67.18 | -89.27 | -234.63 |
Free Cash Flow Free Cash Flow Growth | -498.58 | -190.36 | 153.46 | 211.93 | 112.54 | 287.32 |
Free Cash Flow Growth | - | - | -27.59% | 88.31% | -60.83% | -67.68% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 51.11% | 50.31% | 49.35% | 48.49% | 50.65% | 54.72% |
Operating Margin | 11.70% | 12.54% | 11.78% | 11.21% | 11.02% | 19.67% |
Pretax Margin | 14.52% | 15.49% | 15.30% | 14.70% | 14.13% | 22.31% |
Profit Margin | 10.87% | 11.52% | 11.25% | 10.67% | 10.49% | 16.55% |
FCF Margin | -9.46% | -3.79% | 3.40% | 5.03% | 2.96% | 7.08% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 4.900 | 4.900 | 4.600 | 4.600 | 4.600 | 4.600 |
Dividend Per Share Growth | 6.52% | 6.52% | 0% | 0% | 0% | 9.52% |
Dividend Yield | 0.95% | 0.99% | 0.71% | 0.74% | 0.80% | 0.58% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 25.90 | 24.70 | 36.67 | 39.77 | 42.19 | 34.53 |
Forward PE | - | 25.99 | 25.99 | 25.99 | 25.99 | 25.99 |
P/FCF Ratio | - | - | 121.48 | 84.39 | 149.33 | 80.76 |
PS Ratio | 2.81 | 2.85 | 4.13 | 4.25 | 4.43 | 5.72 |